A detailed history of Regentatlantic Capital LLC transactions in Biogen Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 4,905 shares of BIIB stock, worth $855,432. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,905
Previous 5,103 3.88%
Holding current value
$855,432
Previous $1.04 Million 25.84%
% of portfolio
0.04%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $38,548 - $53,155
-198 Reduced 3.88%
4,905 $1.31 Million
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $260,868 - $310,220
1,391 Added 37.47%
5,103 $1.04 Million
Q1 2022

May 02, 2022

SELL
$193.77 - $244.14 $359,830 - $453,367
-1,857 Reduced 33.35%
3,712 $782,000
Q4 2021

Jan 27, 2022

SELL
$223.92 - $287.77 $275,197 - $353,669
-1,229 Reduced 18.08%
5,569 $1.34 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $34,241 - $44,655
121 Added 1.81%
6,798 $1.92 Million
Q2 2021

Aug 12, 2021

SELL
$259.0 - $414.71 $77,700 - $124,413
-300 Reduced 4.3%
6,677 $2.31 Million
Q1 2021

Apr 29, 2021

SELL
$242.95 - $284.63 $261,657 - $306,546
-1,077 Reduced 13.37%
6,977 $1.95 Million
Q4 2020

Feb 04, 2021

SELL
$236.26 - $355.63 $138,448 - $208,399
-586 Reduced 6.78%
8,054 $1.97 Million
Q3 2020

Oct 13, 2020

SELL
$264.77 - $305.71 $97,170 - $112,195
-367 Reduced 4.07%
8,640 $2.45 Million
Q2 2020

Aug 13, 2020

BUY
$258.66 - $342.55 $87,168 - $115,439
337 Added 3.89%
9,007 $2.41 Million
Q1 2020

May 14, 2020

SELL
$268.85 - $341.04 $30,380 - $38,537
-113 Reduced 1.29%
8,670 $2.74 Million
Q4 2019

Feb 04, 2020

SELL
$220.06 - $304.07 $49,293 - $68,111
-224 Reduced 2.49%
8,783 $2.61 Million
Q3 2019

Oct 22, 2019

BUY
$217.44 - $243.88 $132,203 - $148,279
608 Added 7.24%
9,007 $2.1 Million
Q2 2019

Jul 23, 2019

BUY
$219.29 - $241.72 $643,616 - $709,448
2,935 Added 53.72%
8,399 $1.96 Million
Q1 2019

May 03, 2019

BUY
$216.71 - $338.96 $211,508 - $330,824
976 Added 21.75%
5,464 $1.29 Million
Q4 2018

Jan 30, 2019

SELL
$278.5 - $352.75 $160,137 - $202,831
-575 Reduced 11.36%
4,488 $1.35 Million
Q3 2018

Oct 30, 2018

SELL
$293.51 - $383.83 $18,197 - $23,797
-62 Reduced 1.21%
5,063 $1.79 Million
Q2 2018

Jul 31, 2018

BUY
$257.52 - $306.91 $115,111 - $137,188
447 Added 9.56%
5,125 $1.49 Million
Q1 2018

Apr 23, 2018

SELL
$260.13 - $367.91 $27,313 - $38,630
-105 Reduced 2.2%
4,678 $1.28 Million
Q4 2017

Jan 23, 2018

SELL
$307.64 - $344.58 $92,292 - $103,374
-300 Reduced 5.9%
4,783 $1.52 Million
Q3 2017

Oct 25, 2017

BUY
$281.15 - $329.69 $1.43 Million - $1.68 Million
5,083
5,083 $1.59 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.